CVS HEALTH CORPORATION - CVS STOCK NEWS

CVS Health announced the expansion of COVID-19 testing to children aged 12 and older at over 2,000 drive-thru test sites, effective September 11, 2020. The initiative responds to the urgent need for testing among minors as schools reopen. CVS has also increased its independent lab partners to expedite test result delivery, which typically takes 2–3 days. Self-swab tests are available at no cost to patients, with registration required in advance. To date, CVS has administered over three million COVID-19 tests since March 2020.

CVS Health Corporation (NYSE: CVS) announced that CEO Larry Merlo and CFO Eva Boratto will engage in a fireside chat with investors at the Morgan Stanley 18th Annual Global Healthcare Conference on September 15, 2020, at 8:00 am ET. This event highlights CVS's commitment to evolving as a consumer-centric health company with nearly 10,000 local touchpoints, including innovative HealthHUB® locations. The company is focused on enhancing healthcare accessibility and affordability through various programs designed to manage chronic conditions.

Benedict College and CVS Health have launched a free rapid COVID-19 testing site on the Columbia campus, available to the public by appointment. This collaborative effort aims to enhance access to testing in the community, with operational staffing provided by CVS pharmacists. Testing will run until September 30, 2020, requiring pre-registration via phone. Local leaders, including Congressman Clyburn and Mayor Benjamin, emphasized the importance of testing for public health. CVS also operates over 1,800 drive-thru testing locations nationwide, focusing on vulnerable communities.

CVS Health has announced enhancements to its prescription drug security and disposal initiatives in Massachusetts. The company installed time delay safe technology in all 446 locations in the state, aimed at reducing pharmacy robberies by 50%. Additionally, CVS is adding 50 new safe medication disposal units, expanding its total to 256 in Massachusetts. These measures address the ongoing challenge of prescription drug misuse, especially opioids. CVS has previously donated over 1,000 disposal units to law enforcement and collected over 1.8 million pounds of unwanted medications nationwide.

CVS Health Corporation (NYSE: CVS) announced cash tender offers totaling $6 billion for its 4.000%, 3.700%, and 2.800% Senior Notes due 2023 and 4.100% and 3.875% Senior Notes due 2025. The offers follow the terms outlined in the Offer to Purchase dated August 12, 2020. The 2023 and 2025 Tender Offers will accept validly tendered notes on a prorated basis due to exceeding maximum amounts. The total consideration includes an early tender payment of $30 per $1,000 principal amount for notes tendered before the Early Tender Date on August 25, 2020.

CVS Health Corporation (CVS) has announced early results of its cash tender offers for up to $6 billion in senior notes due in 2023 and 2025. The offers include 4% and 3.7% senior notes due 2023, and 4.1% and 3.875% senior notes due 2025. As of the early tender date on August 25, 2020, significant amounts have been tendered, with notable participation exceeding the maximum amounts set for each note series. CVS plans to accept valid tenders on a prorated basis due to high demand, with settlement expected on August 27, 2020. The total consideration includes an early tender payment of $30 per $1,000.

CVS Health emphasizes the importance of vaccinations amid COVID-19, urging the public to get flu shots this season. A survey revealed that 66% of U.S. consumers intend to receive a flu shot, up from 34% in January 2020, with many opting for earlier immunizations. Flu shots are available at nearly 10,000 CVS Pharmacy and 100 MinuteClinic locations across the U.S. To ensure safety, CVS has implemented health protocols during vaccination. Customers can receive a $5 coupon for a $20 purchase when they get a flu shot, valid until October 31.

CVS Health is expanding its COVID-19 testing capacity by launching 77 additional drive-thru test sites in Florida, bringing the total to 298 locations in the state effective August 21, 2020. This initiative is part of CVS's broader effort to enhance access to testing, with over 1,900 testing locations nationwide since May. Patients will have no out-of-pocket costs as tests are covered by insurance or funded through a program for the uninsured. CVS aims to provide test results within 2-5 days, improving turnaround times through partnerships with independent labs.